147 related articles for article (PubMed ID: 17454631)
21. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
[TBL] [Abstract][Full Text] [Related]
23. Changing patterns in the Epstein-Barr virus (EBV)and Hodgkin lymphoma association in Tunisia.
Dhiab MB; Ziadi S; Saad H; Louhichi T; Trimeche M
Ann Hematol; 2016 Sep; 95(9):1537-43. PubMed ID: 27378019
[TBL] [Abstract][Full Text] [Related]
24. HHV-6 and EBV DNA quantitation in lymph nodes of 86 patients with Hodgkin's lymphoma.
Lacroix A; Jaccard A; Rouzioux C; Piguet C; Petit B; Bordessoule D; Ranger-Rogez S
J Med Virol; 2007 Sep; 79(9):1349-56. PubMed ID: 17607791
[TBL] [Abstract][Full Text] [Related]
25. The correlation of Epstein-Barr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing Hodgkin disease.
Kandil A; Bazarbashi S; Mourad WA
Cancer; 2001 Jun; 91(11):1957-63. PubMed ID: 11391573
[TBL] [Abstract][Full Text] [Related]
26. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
27. Hodgkin lymphoma in Pakistan: an analysis of subtypes and their correlation with Epstein Barr virus.
Fatima S; Ahmed R; Ahmed A
Asian Pac J Cancer Prev; 2011; 12(6):1385-8. PubMed ID: 22126469
[TBL] [Abstract][Full Text] [Related]
28. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
Koh YW; Yoon DH; Suh C; Huh J
Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
[TBL] [Abstract][Full Text] [Related]
29. [Epstein-Barr virus infection and expression of latent membrane protein 2A in Hodgkin's lymphoma of Uygur patients].
Li X; Yang SE; Guo YQ; Zang SH; Guo L; Gulikezi W; Zhao B; Liu W; Bai JP
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):239-42. PubMed ID: 23928530
[TBL] [Abstract][Full Text] [Related]
30. [Morphometric parameters of nuclei in EBV-positive and EBV-negative Hodgkin's lymphoma].
Macák J; Riháková P
Cesk Patol; 2001 Apr; 37(2):57-60. PubMed ID: 11455914
[TBL] [Abstract][Full Text] [Related]
31. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India.
Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995
[TBL] [Abstract][Full Text] [Related]
32. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
Bienemann K; Borkhardt A; Klapper W; Oschlies I
Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
[TBL] [Abstract][Full Text] [Related]
33. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.
Hohaus S; Santangelo R; Giachelia M; Vannata B; Massini G; Cuccaro A; Martini M; Cesarini V; Cenci T; D'Alo F; Voso MT; Fadda G; Leone G; Larocca LM
Clin Cancer Res; 2011 May; 17(9):2885-92. PubMed ID: 21478335
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus infection is not the sole cause of high prevalence for Hodgkin's lymphoma in Saudi Arabia.
Al-Kuraya K; Narayanappa R; Al-Dayel F; El-Solh H; Ezzat A; Ismail H; Belgaumi A; Bavi P; Atizado V; Sauter G; Simon R
Leuk Lymphoma; 2006 Apr; 47(4):707-13. PubMed ID: 16690530
[TBL] [Abstract][Full Text] [Related]
35. Investigation of miR9-1, miR9-2 and miR9-3 Methylation in Hodgkin Lymphoma.
Ben Dhiab M; Ziadi S; Louhichi T; Ben Gacem R; Ksiaa F; Trimeche M
Pathobiology; 2015; 82(5):195-202. PubMed ID: 26337487
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
[TBL] [Abstract][Full Text] [Related]
37. The Value of Torque Teno Virus (TTV) as a Marker for the Degree of Immunosuppression in Adult Patients after Hematopoietic Stem Cell Transplantation (HSCT).
Schmitz J; Kobbe G; Kondakci M; Schuler E; Magorsch M; Adams O
Biol Blood Marrow Transplant; 2020 Apr; 26(4):643-650. PubMed ID: 31712192
[TBL] [Abstract][Full Text] [Related]
38. [Epstein-Barr virus presence in Colombian Hodgkin lymphoma cases and its relation to treatment response].
Quijano S; Saavedra C; Fiorentino S; Orozco O; Bravo MM
Biomedica; 2004 Jun; 24(2):163-73. PubMed ID: 15495596
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women.
Clarke CA; Glaser SL; Dorfman RF; Mann R; DiGiuseppe JA; Prehn AW; Ambinder RF
Cancer; 2001 Apr; 91(8):1579-87. PubMed ID: 11301409
[TBL] [Abstract][Full Text] [Related]
40. Association of Hodgkin's lymphoma with Epstein Barr virus infection.
Cickusić E; Mustedanagić-Mujanović J; Iljazović E; Karasalihović Z; Skaljić I
Bosn J Basic Med Sci; 2007 Feb; 7(1):58-65. PubMed ID: 17489771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
